AI predicts risk of kidney disease from eye-screening images
21 Mar 2025
Researchers have used artificial intelligence to analyse retinal-screening images from people with type 2 diabetes to predict who is at risk of future kidney disease.
Researchers at the Universities of Dundee and Glasgow have developed an innovative approach to predicting whether people with type 2 diabetes are likely to develop chronic kidney disease. Insights into kidney health are provided using artificial intelligence (AI) to analyse images taken during routine diabetes eye screening. This enables kidney problems to be detected long before current tests can identify them or before symptoms arise.
Diabetic kidney disease can often go undetected until it becomes severe. It represents a great burden for the individuals affected and to health services. One in five people with diabetes needing treatment for kidney disease within their lives.
The retina provides the only opportunity for the fragile networks of capillaries that are critical to the health of organs to be conveniently visualised. In the UK, everyone with diabetes aged 12 years and above is invited to attend regular eye screening, during which photographs are taken of the retina to spot signs of damage.
The researchers took nearly one million screening photographs from 100,000 people with type 2 diabetes and linked them with existing data on kidney health. The AI tool was trained to distinguish between images from people with and without kidney disease. The tool was then validated with data from around 30,000 other people with type 2 diabetes.
It was able to detect existing kidney disease with 86% accuracy. Furthermore, in people without kidney disease, it was able to predict who would go on to develop it in the next 5 years with 78% accuracy. By detecting future risk where standard kidney function tests provide no warning, it is hoped that AI will allow for earlier interventions, so that kidney disease progression can be slowed or halted.
By detecting future risk where standard kidney function tests provide no warning, it is hoped that AI will allow for earlier interventions, so that kidney disease progression can be slowed or halted.
Free for all UK & Ireland healthcare professionals
Sign up to all DiabetesontheNet journals
By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.
Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.
We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.
Journal of
Diabetes Nursing
Issue:
Early View
AI predicts risk of kidney disease from eye-screening images
Researchers at the Universities of Dundee and Glasgow have developed an innovative approach to predicting whether people with type 2 diabetes are likely to develop chronic kidney disease. Insights into kidney health are provided using artificial intelligence (AI) to analyse images taken during routine diabetes eye screening. This enables kidney problems to be detected long before current tests can identify them or before symptoms arise.
Diabetic kidney disease can often go undetected until it becomes severe. It represents a great burden for the individuals affected and to health services. One in five people with diabetes needing treatment for kidney disease within their lives.
The retina provides the only opportunity for the fragile networks of capillaries that are critical to the health of organs to be conveniently visualised. In the UK, everyone with diabetes aged 12 years and above is invited to attend regular eye screening, during which photographs are taken of the retina to spot signs of damage.
The researchers took nearly one million screening photographs from 100,000 people with type 2 diabetes and linked them with existing data on kidney health. The AI tool was trained to distinguish between images from people with and without kidney disease. The tool was then validated with data from around 30,000 other people with type 2 diabetes.
It was able to detect existing kidney disease with 86% accuracy. Furthermore, in people without kidney disease, it was able to predict who would go on to develop it in the next 5 years with 78% accuracy. By detecting future risk where standard kidney function tests provide no warning, it is hoped that AI will allow for earlier interventions, so that kidney disease progression can be slowed or halted.
By detecting future risk where standard kidney function tests provide no warning, it is hoped that AI will allow for earlier interventions, so that kidney disease progression can be slowed or halted.
What’s hot in diabetes nursing? October 2026
Diabetes technology care: a National Competency Framework and affiliated assessment tool
Bridging the gap: Why nurses must drive the diabetes clinical research agenda
Risk to ketone test strip availability: Guidance says to prioritise blood ketone testing for patients at greatest risk of DKA
Dual versus single oral therapy following type 2 diabetes diagnosis
Kidney health checks: Whose role is it anyway?
GLP-1 receptor agonists and beyond. Part 2: side effects, problems and solutions
Finding it hard to stay on top of the latest developments in diabetes nursing? Our regular feature brings together carefully chosen resources, publications
23 Oct 2026
A practical competency framework and assessment tool to support all health care professionals in delivering care for people using diabetes technology
22 Oct 2026
Editor-in-chief, Julie Brake discusses how nurse-led research is important to improving the care of people with diabetes.
19 Oct 2026
NHS England temporary guidance following test shortages
16 Oct 2026